We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The EMA’s Committee for Medicinal Products for Human Use recommended five medicines for European Commission approval and six extended indications at its meeting this month. Read More
Biosimilars reduce individual patient’s out-of-pocket medical expenses and lower the financial burden on insurance payers and national health agencies, according to Celltrion CEO Woosung Kee. Read More
Bayer sued Perrigo for allegedly infringing on six patents in its ANDA for a generic version of its acne and rosacea treatment Finacea Foam (azeleic acid). Read More